Bone morphogenic protein (BMP)-4 inhibits proliferation and induces the apoptosis of myeloma cells. However, little is known about the molecular mechanisms of how BMP-4 executes this apoptosis. In this report, we investigated the roles of p53 and the endoplasmic reticulum (ER) in BMP-4-induced apoptosis of mouse hybridoma HS-72 cells. We found that 3 ng/ml of BMP-4 is sufficient to induce the expression of proapoptotic proteins, puma and bax, in a p53-dependent mechanism, and facilitate Ca 2 þ release from the ER to the cytosol, resulting in the activation of caspase-12 and ER dysfunction. Similarly to HS-72 cells, multiple myeloma cells with wild-type p53 genes show much higher sensitivity to BMP-4-induced apoptosis than cells without wild-type p53 genes, suggesting that wild-type p53 status is required for dysfunction of the ER during BMP-4-induced apoptosis in ER-enriched cells, such as hybridoma and myeloma cells. These findings demonstrate that the presence of wild-type p53 genes and enrichment of the ER determines the sensitivity to effective apoptosis by BMP-4, and suggest that ER stress-inducing agents would be valuable in the treatment of multiple myeloma.
Introduction
Apoptosis is a highly regulated mechanism of cell death that is required for normal development and maintenance of tissue homeostasis in multicellular organisms. Conversely, apoptotic dysfunction represents an underlying cause of, or is a contributor to, many diseases. The activation of caspase family proteases is the key step in apoptotic cell death, and several pathways leading to caspase activation and apoptosis have been elucidated (Nagata et al., 2003) . Stress or damage in many organelles including the endoplasmic reticulum (ER) may trigger apoptosis through unknown mechanisms. The ER is a unique cellular compartment involved in protein synthesis and Ca 2 þ homeostasis. Recent evidence is emerging that the ER participates in the initiation of apoptosis induced by the unfolded protein response (UPR), by aberrant Ca 2 þ signaling and by oxidative and metabolic stress. Dysfunction of the ER can trigger caspase activation and, among 14 known caspases, caspase-12 (caspase-4 in humans) seems to be involved in signaling specific to ER-associated apoptosis (Hitomi et al., 2004) . Apoptosis induced by ER stress may be important in chronic neurodegenerative disorders such as Alzheimer's, Parkinson's and Huntington's diseases, and also in ischemia-reperfusion injury (Takuma et al., 2005) .
Multiple myeloma is a B-lymphocyte neoplasia characterized by the slow proliferation of plasma cells in the bone marrow. In vitro, several cytokines with the ability to inhibit proliferation and elicit the apoptosis of myeloma cells have been reported (Bruno et al., 2004; Shapiro-Shelef and Calame, 2004) . Interferon-b and -g inhibit IL-6-dependent proliferation of myeloma cells. Activin-A, a member of the transforming growth factor (TGF)-b superfamily, inhibits proliferation and induces apoptosis of murine plasmacytoma cells (Brosh et al., 1995; Phillips et al., 1999; Zipori and Barda-Saad, 2001 ).
Bone morphogenetic proteins (BMPs), other members of the TGF-b superfamily, are multifunctional cytokines and suppress proliferation and induce the apoptosis of various cells. BMP-7 induces cell cycle arrest of thyroid and prostate carcinoma cells, and overexpression of BMP-6 in murine epidermis results in the suppression of skin tumor formation (Franzen and Heldin, 2001; Wach et al., 2001 ). BMP-2 or -4 and retinoic acid induce apoptosis of pluripotent P19 embryonic carcinoma cells, whereas either BMP or retinoic acid alone shows little effect (Glozak and Rogers, 2001) . As shown in previous reports, treatment with BMP-4 inhibits proliferation and induces apoptosis in some multiple myeloma cell lines and in freshly harvested myeloma cells (Hjertner et al., 2001; Baade Ro et al., 2004) , though the mechanism remains unclear.
In the present study, we investigated the molecular mechanisms by which BMP-4 induces the apoptosis of mouse B-cell hybridoma HS-72 cells. We show that BMP-4 induces expression of puma in a p53-dependent manner and translocation of bax into the ER, which in turn activates caspase-12 through Ca 2 þ release from the ER. Similarly to HS-72 hybridoma cells, BMP-4-induced apoptosis in multiple myeloma cells is highly dependent on wild-type p53 status, resulting in ER dysfunction.
Results

BMP-4 and activin-A suppress proliferation of HS-72 cells
To investigate the molecular mechanism regulating the process of BMP-induced cell death, we first examined the effect of the TGF-b superfamily member ligands on cell viability of mouse B-cell hybridoma HS-72 cells. BMP-4, -6, -7, activin-A and TGF-b1 at various concentrations were added to HS-72 cells under 1% serum conditions for 24 h, and cell viability was determined. As shown in Figure 1a , both BMP-4 and activin-A reduced cell viability at levels as low as 3 ng/ml, and maximal effects were observed at approximately 10 ng/ml for both ligands. BMP-6 and -7 were less potent than BMP-4 and activin-A, and TGF-b1 had no effect on proliferation of HS-72 cells, due to loss of expression in TGF-b type II receptor (data not shown). In addition, exposure of HS-72 cells to 3 ng/ml of BMP-4 or activin-A for 24 h resulted in the typical morphological appearance of apoptosis and DNA ladders ( Figure 1b and data not shown).
As the results of MTT assays determined at 24 h after ligand stimulation reflect the cell death as well as the growth arrest induced by the ligands, we examined whether BMP-4-induced cell death is accompanied by other apoptotic features. BMP-4-treated cells, compared to untreated cells, displayed an increased annexin V-positive population ( Figure 1c and Supplementary Figure S1A) . Notably, the annexin V-positive, propidium iodide (PI)-negative population was also increased in the BMP-4-treated cells. The mitochondrial DCm, an integral component of mitochondrial membrane function, was significantly reduced after BMP-4 treatment ( Figure 1d and Supplementary Figure S1B ). BMP-4 treatment also induced pro-caspase-9 cleavage and caspase-3 activation to a similar extent to tumor necrosis factor-a (TNF-a) (Figure 1e and f), and the latter was inhibited by a caspase-3 specific inhibitor zDEVD-fmk and a broad-spectrum inhibitor zVADfmk (data not shown). These findings indicate that BMP-4 induces the apoptosis of HS-72 cells via, at least in part, activation of caspases through the mitochondrial pathway.
High sensitivity of HS-72 hybridoma cells to ER stress BMP-4 or activin-A induced the apoptosis of HS-72 hybridoma cells at a concentration of approximately 3 ng/ml, whereas higher concentrations of BMP-4 (50 ng/ml or more) are needed to execute the apoptosis of other cells, including endothelial cells and A549 lung carcinoma cells (Kiyono and Shibuya, 2003; Buckley et al., 2004) . To elucidate how lower concentrations of BMP-4 could induce the apoptosis of HS-72 hybridoma cells, we examined the involvement of the ER in the apoptosis of HS-72 cells by the ER stress-inducing drugs, thapsigargin and tunicamycin. These drugs trigger ER-mediated apoptosis by perturbing the normal function of the ER. Thapsigargin and tunicamycin at various concentrations were added to HS-72 cells under 10% serum condition for 4 h. Thapsigargin suppressed the cell viability of HS-72 cells, but had little effect on rat pheochromocytoma PC12 cells, which are known to undergo ER-mediated apoptosis, over this period (Figure 2a ) (Guo et al., 1998; Nishitoh et al., 2002) . Tunicamycin also suppressed the cell viability of HS-72 cells, although it was less potent than thapsigargin. In addition, thapsigargin clearly induced DNA fragmentation and caspase-3 activation at 30 nM with similar effects to TNF-a treatments (Figure 2b and c). Therefore, a low concentration of thapsigargin can induce the apoptosis of HS-72 cells, suggesting that this cell line has a high sensitivity to ER-mediated apoptosis. Thus, it is possible that BMP-4-induced apoptosis of HS-72 cells may also involve the ER.
BMP-4 upregulates puma expression and increases bax translocalization into the ER To further elucidate the molecular mechanism by which BMP-4 induces the apoptosis of HS-72 cells through the ER, we examined the expression of p53 and its target molecules in HS-72 cells incubated with BMP-4 for various time periods. Since the p53 gene is known to be intact in HS-72 cells , we focused on expression profiles of the proapoptotic gene family; puma, bax and noxa, which are downstream targets of p53. Reverse transcription-polymerase chain reaction (RT-PCR) analysis demonstrated that upregulation of puma and bax expression could be observed 12 h after addition of BMP-4 (Figure 3a ). In contrast, noxa was not significantly affected by BMP-4. Cell lysates from HS-72 cells showed increases in puma, p53 and p21waf1 protein levels upon BMP-4 treatment ( Figure 3b ). As the p53 mRNA level is stable following BMP-4 treatment (Figure 3a) , the upregulation of p53 protein levels detected by the immunoblotting might not be transcriptionally controlled, but rather be regulated by modulation of its protein stability.
We next assessed the localization of bax using a subcellular fractionation assay, because bax has been identified as a protein which is translocated into the ER in response to ER stress (Nutt et al., 2002) . In agreement with previous reports, bax was found in the cytosolic fraction, as well as in the mitochondrial fraction in HS-72 cells. Notably, bax was also found in the ER/microsome fraction, and the amount of bax in this fraction was increased by BMP-4 treatment for 24 h (Figure 3c ). The ER membrane contaminated the mitochondrial fraction during the fractionation procedure, as indicated by the presence of the ER membrane protein calnexin in the mitochondrial fraction. However, microsomal and cytosolic fractions were not contaminated by mitochondria, as indicated by the and immunoblotted with a monoclonal antibody to caspase-9. As a positive control for processing of pro-caspase-9, cells were treated with 10 mg/ml of cyclohexamide and 10 ng/ml of TNF-a (TNF) for 4 h. Anti-a-tubulin antibody was used as a loading control.
(f) Caspase-3 activity induced by BMP-4. HS-72 cells were incubated with BMP-4 for 24 h or cyclohexamide and TNF-a (TNF) for 4 h as a positive control, and lysed. The cytosolic extracts were used to measure the activation of caspase-3-like protease activity using DEVD-pNA as a substrate. The cleavage activity is shown as fold increase relative to that of an extract from the untreated cells. Results and s.d. derived in (a) and (f) are typical of at least two independent experiments.
Molecular mechanism of BMP-4-induced apoptosis N Fukuda et al absence of the mitochondria inner membrane protein cox IV in these fractions. Together, these findings demonstrated that bax is localized in the ER/microsome, and this is enhanced by BMP-4. To determine whether ER-targeted bax can perturb the integrity of the ER membrane, we determined the effects of BMP-4 on the activation of caspase-12, which acts downstream of the ER. Caspase-12 is known to be activated and indirectly cleaved by Ca 2 þ released from the ER to the cytosol. We found that cleavage of procaspase-12 was observed at 24 h after BMP-4 treatment (Figure 3d ), and this appeared to occur almost concurrently with caspase-9 activation (Figure 1e ). To determine whether caspase-3 is activated earlier than pro-caspase-9 and -12, a more detailed time course experiment was performed. As shown in Figure 3e , cleavage of pro-caspase-12 was observed from 16 h, and that of pro-caspase-9 and release of cytochrome c were from 20 h after BMP-4 treatment. Cleavage of PARP, a substrate of caspase-3, was observed from 24 h after BMP-4 stimulation. Thus, activation of caspase-12 slightly preceded the caspase-9 activation and cytochrome c release from the mitochondria, leading to sequential activation of caspase-3.
We also determined Ca 2 þ storage in the ER by assessing thapsigargin-induced Ca 2 þ release from the ER. HS-72 cells treated with or without BMP-4 for 24 h were loaded with 1-[6-amino-2-(5-carboxy-2-oxazolyl)-5-benzofuranyloxy]-2-(2-amino-5-methylphenoxy)-ethane-N,N,N 0 ,N 0 -tetra acetic acid, penta acetoxymethyl ester (Fura-2-AM) (3 mM) calcium cytoplasmic probe for 30 min. The peak increase in intracellular Ca 2 þ concentration ([Ca 2 þ ] i ) induced by thapsigargin in a Ca 2 þ -free buffer is therefore proportional to the initial calcium content in the ER ([Ca 2 þ ]er). Figure 3f shows the time course of a typical thapsigargin-induced response. The maximum peak was 490 nM under untreated conditions, whereas the thapsigargin-releasable pool of [Ca 2 þ ]er was completely depleted in cells pretreated with 100 nM of thapsigargin for 30 min (Figure 3f ). The maximum peak of [Ca 2 þ ] i of BMP-4-treated cells was 350 nM, which was significantly lower than that of untreated cells. These findings suggested that caspase-12 was activated by Ca 2 þ released from the steady-state [Ca 2 þ ]er in BMP-4-treated cells. We also performed real-time PCR analysis to investigate whether BMP-4 induces UPR in HS-72 cells. As shown in Figure 3g , expression of chaperons involved in UPR, including CHOP and Bip, was increased following BMP-4 treatment for 24 h. Thus, these findings strongly suggested that BMP-4 could act as ER stress to lead ER dysfunction.
BMP-4-induced apoptosis is highly dependent on endogenous p53 status in multiple myeloma cells As BMP-4 has been shown to inhibit proliferation and induce the apoptosis of some myeloma cells (Kawamura et al., 2002) , we determined whether a low concentration of BMP-4 also induces apoptosis through the ER dysfunction in multiple myeloma cells. To examine the viability of multiple myeloma RPMI8226, U266, NS-1, Molecular mechanism of BMP-4-induced apoptosis N Fukuda et al NC37 and SP-2 cells, we treated the cells with various concentrations of BMP-4 in media containing 1% fetal bovine serum (FBS), and cell viability was measured after 24 h. BMP-4 (3 ng/ml) significantly reduced the viability of HS-72 and SP-2 cells, but had little effect on the myeloma NS-1, U266, NC37 and RPMI8226 cells (Figure 4a ). Cell viability of human breast cancer MCF-7 cells was not significantly affected by these concentrations of BMP-4, even though phosphorylation of Smad1/5 and expression of Inhibitor of Differentiation-1 (Id-1), which is a target gene of BMPs, were induced by BMP-4 with almost similar results compared to HS-72 cells (data not shown).
To know whether BMP-4-induced apoptosis in myeloma SP-2 cells depends on wild-type p53 status and the ER dysfunction, like HS-72 cells, we performed immunoblotting analysis using an anti-p53 antibody. Adriamycin can transcriptionally induce the expression of p53 protein, and thus upregulates the bax and puma gene products in cells expressing wild-type p53. Upon treatment with adriamycin for 4 h, increase in p53 protein was observed in only HS-72, SP-2 and MCF-7 cells, but not in other cells (Figure 4b ). p53 protein level in RPMI8226 cells was constitutively high, but it was not affected by adriamycin treatment (Oh et al., 2000) . Consistent with upregulation of p53 protein, induction of puma and bax genes and that of puma protein were observed only in HS-72, SP-2 and MCF-7 cells, but not in other myeloma cells (Figure 4c and data not shown).
In addition, BMP-4 strongly induced cleavage of procaspase-12 and apoptosis of HS-72 and SP-2 cells (Figures 3d, 4d and e), whereas it had no effect on myeloma cells lacking the wild-type p53 gene or MCF-7 cells, although MCF-7 cells expressed wild-type p53 protein (Figure 4b) (Huang et al., 2002) . These findings strongly suggest that the molecular mechanism by which BMP-4 induces apoptosis in SP-2 cells is similar to that of HS-72 cells. Therefore, endogenous p53 status is important for apoptosis induced by low concentrations of BMP-4 in multiple myeloma cells, but not in MCF-7 cells. In addition, we generated a p53 dominant-negative mutant to suppress endogenous p53 activity. HS-72 cells infected with adenovirus encoding a p53 dominantnegative C135Y mutant (p53 mt135) were analysed by immunoblotting and MTT assays (Supplementary Figure S2A and B) . In this experiment, the media containing 5% serum was chosen to get optimal condition for adenovirus infection. Although cell death by BMP-4 under 5% serum condition was less than that under 1% serum condition (Supplementary Figure S2B and Figure 1a) , it was significantly suppressed by infection with the dominant-negative p53 mutant. Futhermore, BMP-4-induced puma expression was reduced by overexpression of the p53 dominant-negative mutant (Supplementary Figure S2C) . These findings strongly suggest that BMP-4 induces the expression of puma and apoptosis of HS-72 cells by a p53-dependent mechanism. 
Discussion
In the present study, we investigated the role of caspases and the ER in the execution of BMP-4-induced apoptosis. We found that 3 ng/ml of BMP-4 was sufficient to fully induce the apoptosis of HS-72 and SP-2 cells. In the presence of a broad-spectrum caspase inhibitor zVAD-fmk, BMP-4-induced apoptosis was almost completely suppressed (our unpublished data), suggesting that BMP-4-induced apoptosis is largely dependent on caspase activity. Previous reports showed that a concentration of 50 ng/ml or higher of BMP-4 was required to induce the apoptosis of A549 lung adenocarcinoma and HUVEC capillary endothelial cells (Kiyono and Shibuya, 2003; Buckley et al., 2004) , whereas 3 ng/ml is sufficient to induce the apoptosis of HS-72 and SP-2 cells. Both cells have a wild-type p53 gene, which upregulates the expression of puma and bax. Bax collaborates with puma, and has the ability to induce mitochondrial and ER dysfunction through membrane perturbation. The importance of BH-3-only proteins on apoptosis induced by the ER dysfunction may explain the observation that bax À/À bak À/À cells and puma À/À cells are resistant to almost all death stimuli including ER stress (Reimertz et al., 2003) , and that overexpression of these proteins promotes Ca 2 þ release from the ER (Pan et al., 2001 ). However, MCF-7 cells expressing wild-type p53 gene were not sensitive to BMP-4-induced apoptosis, suggesting that the presence of a wild-type p53 gene is not enough for execution of BMP-4-induced apoptosis, and additional mechanisms exist in HS-27 and SP-2 cells. One possibility is the ER environment of these cells. Histological and pathological findings indicated that myeloma cells, as well as hybridoma cells, have numerous ER and Golgi apparatus to secrete large amounts of immature proteins, including immunoglobulins. It appears that the ER in these cells are continuously fulfilling this function, thus exposing the cells to ER stress, which is known as the UPR. Supporting this notion, BMP-4 induced the expression of chaperons, BiP and CHOP, in HS-72 cells.
The UPR is activated by the appearance of misfolded and/or aggregated proteins in the ER. Eukaryotic cells possess at least three different mechanisms to adapt to or remove ER stress including UPR, and thereby survive: (1) the ER-associated degradation pathway to restore the folding capacity; (2) transcriptional activation of genes encoding ER-resident chaperones; and (3) translational attenuation to limit further UPR. When the cells are exposed to prolonged or strong ER stress and homeostasis cannot be maintained, the ER stress initiates a pathological trajectory or apoptosis. This switch, from metabolic arrest, which provides an opportunity for repair of the ER folding capacity, to apoptosis, which eliminates overly damaged cells, is dependent on cell-specific contexts. Therefore, as myeloma cells would be always exposed to the UPR and the mechanisms to protect from ER stress, additional ER stress from BMP-4 could easily turn on this switch to induce effective apoptosis. Thus, MCF-7 cells were not sensitive to BMP-4-induced apoptosis even though they had wild-type p53 gene and transduced BMP signals normally.
The molecular mechanism by which BMP-4 induces the expression of puma and bax mRNAs is still not clear. A recent report indicated that p53 directly binds to Smad2 in a TGF-b-dependent manner during Xenopus embryonic development and synergistically activates TGF-b-induced transcription (Cordenonsi et al., 2003) . However, it has not been shown whether Smad2 could activate p53-dependent transcription. In our present study, the expression of puma and bax was upregulated following an increase in p53 protein stability caused by BMP-4 treatment. Smad1/5 could bind to p53 (Takebayashi-Suzuki et al., 2003) , raising the possibilities that Smad1/5 signals cooperatively activate p53-dependent transcription through regulating post-translational modification of p53, such as phosphorylation or acetylation, or perturb the physical interaction between MDM2 and p53 thus protecting p53 from degradation. On the other hand, BMP-4 had a minor effect on the apoptosis of myeloma cells lacking p53, but inhibited their proliferation at relatively high doses (30 ng/ml or more) through upregulation of p21waf1 (data not shown) (Kawamura et al., 2000) . Taken together, BMP-4-induced apoptosis would be dependent on collaboration between Smads and p53. However, there is no evidence that BMPSmad-signals affect p53 function, and therefore it will be interesting to study how BMPs regulate p53 protein stability.
In conclusion, the results presented here strongly suggest that apoptotic signals from the ER are an important mechanism in the execution of BMP-4-induced apoptosis, and that BMP-4-induced apoptosis is highly dependent on wild-type p53 status and viability of the ER itself in myeloma cells. However, further investigations will be needed to elucidate other signaling pathways that are involved in BMP-4-induced cell death in multiple myeloma cells. ER stress has been implicated in the pathogenesis of some human diseases, such as Alzheimer's disease, Parkinson's disease and neurodegenerative disorders. Therefore, it has been suggested that reduction in the ER stress in nerve cells of these disorders protected cells from apoptosis and thereby lead cells to survive. However, our current data strongly suggest that augmentation of the ER stress could be used as a new strategy for treatment of some diseases including multiple myeloma.
Materials and methods
Cell culture
Mouse B-cell hybridoma HS-72 cells (a gift from Dr K Yamato, Tokyo Medical and Dental University, Japan) (Yamato et al., 2001) were maintained in RPMI1640 (Sigma, St Louis, MO, USA) supplemented with 10% FBS, 10 mM HEPES (Gibco), 100 U/ml penicillin (Gibco) and 100 mg/ml streptomycin (Gibco). Multiple myeloma U266 cells were obtained from the American Type Culture Collection (Rockville), NS-1 and SP-2 cells were obtained from Dr M Takahashi (Nihon Medical University, Japan), and RPMI8226 and NC37 cells were obtained from the Cell Resource Center for Biomedical Research (Tohoku University, Japan). These cells were maintained in RPMI1640 containing 10% FBS, with 100 U/ml penicillin and 100 mg/ml streptomycin. Human breast cancer MCF-7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin. Rat pheochromocytoma PC12 cells donated by Dr H Kadowaki (Tokyo Medical and Dental University) were cultured in DMEM with 10% FBS and 10% heat-inactivated horse serum, 100 U/ml penicillin, and 100 mg/ml streptomycin. All cells were cultured in a 5% CO 2 atmosphere at 371C.
Reagents and antibodies TGF-b1 and BMP-4, -6, and -7 were purchased from R&D Systems, and activin-A was from Sigma. Thapsigargin and tunicamycin were purchased from Wako Chemicals. Anticaspase-9 and anti-cytochrome c antibodies were from MBL. Anti-caspase-12 and anti-PARP antibodies were purchased from Cell Signaling. Anti-p53 antibody was purchased from Novocastra Laboratories Ltd. Anti-bax and anti-p21 antibodies were purchased from Santa Cruz, and anti-a-tubulin and anti-puma antibodies were purchased from Sigma. Anticox IV and anti-calnexin antibodies were purchased from Molecular Probes and Stressgene, respectively.
DNA fragmentation assay
After cells were stimulated with indicated concentrations of BMP-4 in RPMI1640 medium containing 1% FBS for 24 h, cells were lysed with a lysis buffer (20 mM Tris-HCl, pH 7.5, 10 mM EDTA and 0.5% Triton X-100). Cell extracts were clarified by centrifugation and further incubated with 0.1 mg/ml ribonuclease (RNase) A (Sigma), and 0.2 mg/ml proteinase K (Sigma) at 421C for 1 h. DNA was purified by standard phenol-chloroform extraction and ethanol precipitation. Dry DNA pellets were then resuspended in TE containing 0.2 mg/ml RNase A, and samples were electrophoretically separated on 2% agarose gel containing 0.5 mg/ml ethidium bromide.
Apoptosis assay by flow cytometry Cells were treated with 3 ng/ml of BMP-4 in RPMI1640 medium containing 1% FBS for 36 h. Cells were washed once with PBS, and resuspended in PBS containing 50 mg/ml PI (Pharmingen) and 0.1 mg/ml RNase A, incubated for 30 min at 371C in the dark, and then analysed by a FACScan flow cytometer (Beckman Coulter). To perform annexin V staining, cells were washed with PBS and resuspended in a binding buffer containing 10 mM HEPES, pH 7.4, 140 mM NaCl and 2.5 mM CaCl 2 . After 10 min incubation with 25 mg/ml annexin V-fluorescein isothiocyanate and 12.5 mg/ml PI on ice in the dark, the fluorescence emitted by cells (10 000 cells/sample) was analysed by a FACScan flow cytometer.
Mitochondrial membrane potential assay Cells were cultured with 3 ng/ml of BMP-4 for 36 h. After 15 min incubation with 10 mM of the fluorescence probe dihydrhodamine 123 (Rh 123; Wako) at 371C in the dark, cells were centrifuged for 5 min at 1500 g, and the intracellular fluorescence intensity was measured in a FACScan flow cytometer.
Immunoblotting analysis
Cells were lysed in a RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate and 0.1% SDS). Cell extracts were clarified by centrifugation and resolved on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) followed by electroblotting onto polyvinylidene difluoride membranes (Fluorotrans, Pall). After blocking with 5% skim milk in TBS-T (50 mM Tris-HCl, pH 8.0, 150 mM NaCl and 0.1% Tween-20) for 1 h, the membranes were probed with antibodies. The antibody-antigen complexes were detected using the ECL system (Amersham Pharmacia Biotech). The cytosolic fraction for cytochrome c was prepared by selective membrane permeabilization with digitonin (Cho et al., 2005; Sun and Leaman, 2005) . In brief, cells were exposed to 0.05% digitonin in an isotonic sucrose buffer (250 mM sucrose, 10 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA and 1 mM EGTA) for 5 min at room temperature to collect the soluble fraction as cytosolic extracts. Anti-atubulin antibody was used as a loading control.
Measurement of caspase-3 activity
Caspase-3-like activity was measured using a CPP32/caspase-3 colorimetric protease assay kit (MBL) following the manufacturer's instructions, in which a spectrophotometric DEVDchromophore p-nitroanilide (pNA) was used as a substrate.
Determination of cell viability (MTT assay)
Cell viability was determined using a cell counting reagent (Nakalai), in which 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt (WST-8) was used as a substrate. The relative number of surviving cells was determined in duplicate by estimating the value of control (untreated) cells as 100%.
RT-PCR analysis
Total RNA was isolated from HS-72 cells with an RNeasy kit (Qiagen), and first-strand cDNA was synthesized using the Superscript III First-strand Synthesis System (Invitrogen) with random hexamer primers as described by the manufacturer's instructions. The PCR primers used were as follows: GAPDH: sense, 5 0 -TGCAGTGGCAAAGTGGAGATT-3 0 , antisense, 5 0 -TTGAAGTCGCAGGAGACAACCT-3 0 ; p21 waf1 : sense, 5 0 -GCGACTGTGATGCGCTAATG-3 0 , antisense, 5 0 -CCAGT GGTGTCTCGGTGACA-3 0 ; bax; sense, 5 0 -ATGGAGCTGC AGAGGATGATTG-3 0 , antisense, 5 0 -CCCATTCATCCCA GGAAAATG-3 0 ; puma: sense, 5 0 -ACCTCAACGCGCAGTA CGA-3 0 , antisense, 5 0 -GGCAGTCCAGTATGCTACATGG-3 0 ; noxa: sense, 5 0 -CTTGAAGGACGAGTGTGCTCAA-3 0 , antisense, 5 0 -ACGACTGCCCCCATACAATGT-3 0 ; p53: sense, 5'-TCACAGCACATGACGGAGGT-3 0 , antisense, 5'-CTCTCGGAACATCTCGAAGC-3 0 .
Real-time PCR
Quantitative real-time PCR analysis was performed using the ABI PRISM 7000 Sequence Detection System (Applied Biosystems). The primer sequences used were as follows: CHOP: sense, 5 0 -TGAGTCCCTGCCTTTCACCTT-3 0 , antisense, 5 0 -TGCCCCCATTTTCATCTGAG-3 0 ; Bip: sense, 5 0 -TACTTCAATGATGCCCAGCG-3 0 , antisense, 5 0 -CCAGG CCATATGCAATAGCA-3 0 .
Subcellular fractionation
Cells were treated with BMP-4 for 20 h. Cells were resuspended in a hypotonic buffer (250 mM sucrose, 20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA and a protease inhibitor cocktail (Sigma)) on ice for 30 min. Cells were disrupted by passing through 26-gauge needles 30 times, and through 30-gauge needles more than 20 times. Cell lysates were centrifuged at 750 g for 10 min at 41C to get rid of unlysed cells and nuclei. The supernatant was centrifuged at 10 000 g for 20 min at 41C. The pellet was saved as the mitochondrial fraction. The supernatant was further centrifuged at 100 000 g for 1 h at 41C. The pellet was saved as the ER/microsome fraction. Both mitochondrial and ER fractions were lysed in a RIPA buffer for immunoblotting analysis.
Measurement of [Ca 2 þ ] i [Ca 2 þ ] i was measured by the method described by Grynkiewicz et al. (1985) . Briefly, cells were resuspended in RPMI1640 medium with 1% FBS in the presence or absence of 10 ng/ml BMP-4 for 24 h and then loaded with 3 mM of Fura-2-AM (Dojindo) at 371C for 30 min. Loaded cells were washed once with PBS, once with a calcium-free buffer (120 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 0.96 mM NaH 2 PO 4 , 0.2% glucose, 0.1% bovine serum albumin, and 20 mM HEPES, pH 7.4) and resuspended in 3 ml of the same calcium-free buffer for the determination of the cytosolic free Ca 2 þ concentration ([Ca 2 þ ] i ). A 1.5 ml cell suspension was added to a quartz cuvette, and the fluorescence measured at 371C with a CAF-110 spectrofluorometer (Nihon Bunkou) with excitation at 340 and 380 nm and emission at 500 nm. [Ca 2 þ ] i was calculated from the ratio of fluorescence intensities (Grynkiewicz et al., 1985) .
Abbreviations TGF-b, transforming growth factor-b; BMP, bone morphogenetic protein; ER, endoplasmic reticulum; UPR, unfolded protein response; Rh 123, fluorescence probe dihydrhodamine 123; WST-8, 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt; Fura-2-AM, 1-[6-amino-2-(5-carboxy-2-oxazolyl)-5-benzofuranyloxy]-2-(2-amino-5-methylphenoxy)-ethane-N,N,N 0 ,N 0 -tetra acetic acid, penta acetoxymethyl ester; PI, propidium iodide; TNF-a, tumor necrosis factor-a.
